STAT

Opinion: A makeover for oral PrEP: designing real-world HIV prevention for women

In parts of the world where women don't have much personal power, design-led solutions can transform prevention of HIV from a source of shame into an empowering ritual of self-care.

When Manu (an alias of her choosing) got married, she never suspected her future husband had something to hide — something that would change her life and health forever. He came from a respectable family and had a good job. The only clue was perhaps the rushed wedding, which took place just 20 days after they met.

Manu told me her story as we sat in her cramped bedroom in Delhi. She was sipping tea as I filmed the conversation. I kept my promise not to film her face. Revealing her identity was a risk she couldn’t take. It could mean her — and her parents — losing everything, including her job, their home, and their place in their community.

A few months after

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Plans For Generic Wegovy, Cough Syrup Warnings, And More
Biocon is developing a generic version of Novo Nordisk's Wegovy and is prepared to conduct a clinical trial next year if needed.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.

Related Books & Audiobooks